St John’s Wort Complementary Therapy for ADHD

A randomized, double-blind, placebo-controlled trial of hypericum perforatum (St John’s Wort) in the treatment of attention-deficit/hyperactivity disorder (ADHD) was conducted in 54 children aged 6 to 17 years at Bastyr University, Kenmore, WA.

Bibliographic Details
Main Author: J Gordon Millichap
Format: Article
Language:English
Published: Pediatric Neurology Briefs Publishers 2008-06-01
Series:Pediatric Neurology Briefs
Subjects:
Online Access:https://www.pediatricneurologybriefs.com/articles/905